Informational

Data use:

We use cookies and similar tools to make your use of this website easy and to keep it working properly. We may share data about you and how you use the site with third parties, such as analytics and marketing partners. Learn more in our Privacy Policy and Terms of Use. By continuing to use the site, you agree to this.

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Brinsupri™ (brensocatib) – New drug approval

August 12, 2025 - Insmed announced the FDA approval of Brinsupri (brensocatib), for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients 12 years of age and older.

Download PDF

© 2026 Optum, Inc. All rights reserved. Stock photos used.